1 Reason I Wouldn’t Buy Barclays PLC Today

Today I am looking at why Barclays (LSE: BARC) (NYSE: BCS.US) could be considered a risky share selection.

Courtroom chaos rolls on and on

Unfortunately for Barclays, there appears to be no end to the steady stream of misconduct allegations stretching back to before the 2008/2009 banking crisis, a situation that could cause a significant drain on the balance sheet as the prospect of severe financial penalties drags on.

Most notably Barclays is currently locked in controversy over its ‘dark pool’ private trading platform, with the New York attorney general asserting that the bank had “demonstrated a disturbing disregard for its investors in a systematic pattern of fraud and deceit” to benefit its high-frequency traders.

In an unusual step Barclays has elected to vigorously fight the case in court rather than negotiate a settlement with regulators. But the Barclaysconsequences of the case could result in catastrophic fines for the bank if found guilty, not to mention the wider effect of Barclays’ being dragged through the mud once again — volumes at the firm’s trading platform have already fallen through the floor since the claims emerged.

And the firm’s legal team received a further blow to the solar plexus this week when it, along with more than a dozen other banks including HSBC and Royal Bank of Scotland, was hit with a $1.15bn lawsuit from the US State of Virginia. The plaintiff claims that the banks defrauded the state’s retirement fund by selling it sub-standard mortgage bonds between 2004 and 2010.

Barclays, like the majority of the UK’s biggest banking players, has also had to set aside vast sums to cover a vast array of misdeeds. The mis-selling of payment protection insurance (PPI) has been one of the biggest headaches for the bank, and Barclays added a further £900m for redress during January-June.

Figures released last month suggested that the company could be turning the corner on this front, however, with new general insurance and PPI complaints toppling by 37% to 182,564 during the first half. But since then the Financial Conduct Authority (FCA) ordered 2.5 million cases assessed between 2012 and 2013, where claims may have been wrongly rejected or claimants undercompensated, to be reappraised.

By the looks of things Barclays looks set to remain locked in costly litigation battles for some time to come, making a final bill nigh-on impossible to predict but which could have a hugely-detrimental effect on earnings.

3 firms we believe should surge in the current climate

But regardless of whether you fancy investing in Barclays, and are looking to maximise your chances of making a mint from your shares portfolio, I would urge you to check out this EXCLUSIVE Fool report which highlights many of the pitfalls that can seriously whack your investment returns.

This special publication -- "This Bull Market Could Become A Dangerous Rodeo Ride" -- picks out a handful of stock market stars poised to make stunning gains over the next 12 months, and tells you how to avoid those most likely to tank. Click here to enjoy this BRAND NEW report -- it's totally free and comes with no further obligation.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.